The EMA has approved two updated vaccines for the Omicron variant

The EMA has approved two updated vaccines for the Omicron variant
The EMA has approved two updated vaccines for the Omicron variant

The time is counting down for the two updated vaccines that also cover the Omicron variant of the coronavirus to be released on the market.

Twenty-four hours after approval by the FDA, the European Medicines Agency (EMA) approved updated vaccines from Pfizer and Moderna, which provide broader protection against the coronavirus and its variants.

ADVERTISING

The vaccines “target Omicron’s BA.1 subvariant plus the original strain” of the coronavirus, which emerged in the Chinese city of Wuhan in 2019, the Amsterdam-based EMA said.

The new vaccines are intended to be given to people aged 12 and over who have already been vaccinated at least once against Covid-19, the European Medicines Agency (EMA) announced. These vaccines are adapted versions of Pfizer/BioNTech’s original Comirnaty and Moderna’s Spikevax vaccines.

ADVERTISING

They do not, however, target the virulent BA.4 and BA.5 subvariants of the ‘Omicron’ variant, which have emerged in recent months as the dominant strains worldwide.

The European Medicines Agency announced earlier today that it is supporting the two separately updated Covid-19 vaccines to be given as booster doses targeting the Omicron variant, as the old continent prepares to start vaccination to fight winter infections.

The new so-called bivalent doses work against Omicron’s BA.1 subvariant and the original virus first detected in China.

The article is in Greek

Tags: EMA approved updated vaccines Omicron variant

PREV Coronavirus: High doses of folic acid appear to increase risk
NEXT Meeting of Volokolamsk Antonio with Patriarch John of Antioch